TAIP training: introduction to psychedelic-assisted therapy

Would you like a science-based overview of psychedelic-assisted therapy and its role in today’s mental health care?

The training gives an introductory, evidence-based overview of the treatment, how it works, the treatment process and developments in Estonia and worldwide. It combines lectures with discussion and leaves room for questions.

Topics:

• psychedelic medicines (ketamine, psilocybin, MDMA: their effects on brain and mind, and the scientific evidence)

• psychedelic-assisted therapy (stages, indications and contraindications, the therapist’s role, set and setting, ethics and safety)

• modern clinical research and drug development (esketamine, ketamine, psilocybin, MDMA, 5-MeO-DMT)

• international practice (Canada, Australia, Switzerland, Germany, Czechia and Estonia)

Trainer: Ethel Rosenfeldt, psychologist-counsellor who is completing the ADEPT programme in psychedelic-assisted therapy at the OPEN Foundation in the Netherlands.

Suitable for psychologists, psychotherapists, psychiatrists, mental health nurses and other specialists, as well as decision-makers in health and policy.

Schedule (may change):

10:15–11:30 block I: psychedelics

11:30–11:45 coffee break

11:45–13:00 blocks II–III: psychedelic-assisted therapy and clinical research

13:00–13:30 lunch break

13:30–15:00 block IV: international practice and summary

Date and place: 4 December 2026, 10:15–15:00, Ülemiste City, Öpiku Conference Centre, Supernova room, Valukoja 8, Tallinn.

Fee: €175 (includes coffee and lunch breaks and VAT). Participants: 10–48. Organiser: SA TAIP, which may cancel the training if the minimum number of participants is not reached; the fee is then refunded in full.